Diphtheria clinical trials
The registry lists 265 studies for Diphtheria across more than 10 countries. 16 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-08.
Status
- Completed
- 225
- Status unknown
- 11
- Not yet recruiting
- 8
- Active, not recruiting
- 7
- Recruiting
- 7
- Withdrawn
- 3
Phase
- Phase 3
- 123
- Phase 4
- 58
- Phase 2
- 38
- Phase 1
- 17
Where
- United States
- 49
- China
- 29
- Korea, Republic of
- 16
- Philippines
- 16
- Canada
- 14
- Thailand
- 11
Who runs them
GlaxoSmithKline (94) · Sanofi Pasteur, a Sanofi Company (63) · Sanofi (18) · CanSino Biologics Inc. (7) · LG Chem (6) · Merck Sharp & Dohme LLC (6) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Novartis Vaccines (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 265 — search for more.
- Study of BK1803 in Healthy InfantsNot yet recruitingNCT07793513Phase 31 country
- A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined VaccineNot yet recruitingNCT07744347
- Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in PregnancyRecruitingNCT07097012Phase 41 country
- Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months OldNot yet recruitingNCT07621341Phase 41 country
- Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme TrialRecruitingNCT06815250Not applicable1 country
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Not yet recruitingNCT07492303Phase 1
- Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) VaccineNot yet recruitingNCT07418372Phase 1/21 country
- Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined VaccineRecruitingNCT07203755Phase 11 country
- BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in AfricaEnrolling by invitationNCT07005726Phase 41 country
- Study of Concomitant Administration of the sIPV and DTaP or MMRNot yet recruitingNCT06920069Phase 41 country
- Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeNot yet recruitingNCT06618196Phase 2
- Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in PregnancyRecruitingNCT06135636Phase 41 country
- Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old InfantsRecruitingNCT06605755Not applicable1 country
- Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old InfantsRecruitingNCT06344065Phase 31 country
- Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined VaccineRecruitingNCT06184542Phase 11 country
- A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy AdultsNot yet recruitingNCT05952596Phase 1
- A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant WomenActive, not recruitingNCT07596199Phase 31 country
- Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedNCT05457946Phase 2/31 country
- A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesActive, not recruitingNCT06947499Phase 2/31 country
- A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)CompletedNCT06708286Phase 2/31 country
- A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)CompletedNCT06056050Phase 11 country
- Safety and Immunogenicity Study of Tdap Vaccinations for Plasma DonorsCompletedNCT05662852Phase 21 country
- Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceActive, not recruitingNCT060709611 country
- Safety Monitoring of Boostagen® Vaccine in ThailandCompletedNCT074445021 country
- Study of BK1301 (DTaP Vaccine) as a Booster in AdolescentsCompletedNCT02118961Phase 31 country
- Confirmatory Study of BK1310 in Healthy InfantsCompletedNCT03891758Phase 31 country
- PFAS Exposure and Immune Response to Vaccination in AdultsCompletedNCT06588530Phase 41 country
- A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, AdsorbedActive, not recruitingNCT05091619Phase 31 country
- Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined VaccineActive, not recruitingNCT06857370Phase 31 country
- Cutaneous Diphtheria in France : Observational, Retrospective Study of Patient CharacteristicsCompletedNCT057982471 country
- Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)WithdrawnNCT05482282Phase 31 country
- Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their InfantsCompletedNCT03589768Phase 22 countries
- Immune Response followingTdap Vaccine in PregnancyCompletedNCT040822991 country
- Sero-epidemiological Survey of England in 2019/2020 - COVID-19CompletedNCT040613821 country
- A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)Active, not recruitingNCT05951725Phase 31 country
- Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis VaccineCompletedNCT06817187Phase 31 country
- A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and ToddlersCompletedNCT04535037Phase 43 countries
- Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.CompletedNCT025698791 country
- Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.Active, not recruitingNCT05480462Phase 31 country
- Post Marketing Surveillance of Diphtheria Antitoxin (DAT)CompletedNCT06053853Phase 41 country
- Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruSCompletedNCT02458183Phase 32 countries
- Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in KoreaCompletedNCT015680601 country
- Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .CompletedNCT04099303Phase 11 country
- Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western KenyaCompletedNCT01878435Not applicable1 country
- The Effect of ShotBlocker on Injection PainCompletedNCT05495542Not applicable1 country
- Post Marketing Surveillance for ADACEL™ in South KoreaCompletedNCT01137435Phase 41 country
- Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous DoseCompletedNCT01439165Phase 42 countries
- Surveillance Program to Determine Product Specific Rates of Invasive Hib DiseaseCompletedNCT008558551 country
- DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese InfantsCompletedNCT02274285Phase 31 country
- A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in CanadaCompletedNCT03958799Phase 11 country